presbyopia epidemiology forecast insight

DelveInsight’s ‘Presbyopia - Epidemiology Forecast to 2034’ report delivers an in-depth understanding of the disease, historical and forecasted Presbyopia epidemiology in the 7MM, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Geographies Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2021-2034

Presbyopia Understanding

Presbyopia Overview

Presbyopia, a natural age-related condition, is the result of a gradual decrease in accommodative amplitude, from about 15 diopters (D) in early childhood to 1 D before the age of 60 years. An irreversible, normal physiologic condition that affects all primates, it impairs the ability to see clearly at near. It is a natural part of aging. Presbyopia usually becomes noticeable in the early to mid-40s and continues to worsen until around age 65. Presbyopia can be classified by type which includes incipient presbyopia, functional presbyopia, absolute presbyopia, premature presbyopia, and nocturnal presbyopia. Presbyopia is partly due to age-related changes in the proteins within the lens of the eye that cause it to become thicker, harder, and less flexible. This loss of flexibility affects the lens's ability to refract light rays which, in turn, affects the eye's capacity to focus.

Initial symptoms may be difficulties with prolonged close-up work, with tiring (eye strain) of the eyes. This may be worse in dim light. Other common symptoms are delays in focusing at near or distance, ocular discomfort, headache, asthenopia, squinting, fatigue or drowsiness from near work, increased working distance, need for brighter light for reading, and diplopia. Age is the major risk factor for the development of presbyopia, although the condition may occur prematurely as the result of factors such as trauma, systemic disease, cardiovascular disease, or a drug side effect.

Presbyopia cannot be prevented. It is an inevitable part of aging. However, people who do a lot of close visual work, such as working with a computer or intensive reading, may develop presbyopia earlier than others.

Presbyopia Diagnosis

Presbyopia can be diagnosed by an optometrist, ophthalmologist, or physician, who takes a complete medical history to determine the extent of the vision problem. The doctor also tests the vision by having the patient read the text at a typically comfortable distance. If the diagnosis of presbyopia is confirmed, the doctor may perform a test to determine the extent of the focusing problem and the appropriate lens prescription. In this test, the doctor asks the patient to look through corrective lenses and continues to increase the magnification power until the words on the page are clear and comfortable enough to be read by the patient. A thorough assessment of the health of the eyes and associated structures is an integral component of the comprehensive adult eye and vision examination. This examination can lead to the diagnosis of systemic diseases and disorders that have ocular manifestations.

Epidemiology Perspective by DelveInsight

The Presbyopia epidemiology division provides insights about historical and current Presbyopia patient pool and forecasted trends for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

In the year 2020, the total prevalent case of Presbyopia was 286,994,105 cases in the 7MM which are expected to grow during the forecast period, i.e., 2025-2034.

The disease epidemiology covered in the report provides historical as well as forecasted Presbyopia epidemiology [segmented as Total Prevalent Cases of Presbyopia, Total Diagnosed Cases of Presbyopia, Total Age-specific Cases of Presbyopia, Gender-specific Cases of Presbyopia, Severity-specific Cases of Presbyopia, and Total Treated cases of Presbyopia] in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2021 to 2034.

Country Wise- Presbyopia Epidemiology

Estimates show that the highest cases of Presbyopia in the 7MM were in the United States, followed by Germany, Japan, Italy, France, the United Kingdom, and Spain in 2020.

• In the 7MM, the total diagnosed cases of Presbyopia was 246,336,607 cases in the year 2020, which will probably rise during the forecast period, i.e., 2025-2034.
• In the 7MM, the total gender-specific cases of Presbyopia were 98,534,643 for males and 147,801,964 for females in the year 2020.
• In the 7MM, the total age-specific cases of Presbyopia were 70,036,878, 80,546,882, 58,274,618, and 37,478,227 cases for the age group less than 60 years, 60-69, 70-79, and ≥80 years, respectively in 2020.
• In the 7MM, the total severity-specific cases of Presbyopia were 49,267,321 and 197,069,285 for mild cases and moderate to severe cases, respectively in the year 2020.
• In the 7MM, the total treated cases of Presbyopia was 197,069,285 cases in the year 2020, which will probably rise during the forecast period, i.e., 2025-2034.
• In the United States, the total number of prevalent cases of Presbyopia was 117,369,699 cases in the year 2020 which are expected to grow during the forecast period, i.e., 2025-2034.
• In the year 2020, the total prevalent cases of Presbyopia were 134,726,460 cases in EU-5 which are expected to grow during the forecast period, i.e., 2025-2034.
• In Japan, the total number of prevalent cases of Presbyopia was 34,897,947 cases in the year 2020 which are expected to grow during the forecast period, i.e., 2025-2034.

Scope of the Report

• The Presbyopia report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns.
• The Presbyopia Report and Model provide an overview of the risk factors and global trends of Presbyopia in the seven major markets (7MM: The United States, Germany, France, Italy, Spain, and the United Kingdom, and Japan)
• The report provides insight about the historical and forecasted patient pool of Presbyopia in the seven major markets covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
• The report helps to recognize the growth opportunities in the 7MM concerning the patient population.
• The report assesses the disease risk and burden and highlights the unmet needs of Presbyopia.
• The report provides the segmentation of the Presbyopia epidemiology by total prevalent cases in the 7MM.
• The report provides the segmentation of the Presbyopia epidemiology by total diagnosed cases in the 7MM.
• The report provides the segmentation of the Presbyopia epidemiology by total age-specific cases in the 7MM.
• The report provides the segmentation of the Presbyopia epidemiology by gender-specific cases in the 7MM.
• The report provides the segmentation of the Presbyopia epidemiology by severity-specific cases in the 7MM.
• The report provides the segmentation of the Presbyopia epidemiology by treated cases in the 7MM.

Report Highlights

• 10-Year Forecast of Presbyopia epidemiology
• 7MM Coverage
• Total Prevalent Cases of Presbyopia
• Total Diagnosed Cases of Presbyopia
• Total Age-Specific Cases of Presbyopia
• Gender-Specific Cases of Presbyopia
• Severity-Specific Cases of Presbyopia
• Treated Cases of Presbyopia

KOL-Views

We interview KOL’s and SME's opinions through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

• What will be the growth opportunities in the 7MM concerning the patient population of Presbyopia?
• What are the key findings of the Presbyopia epidemiology across the 7MM and which country will have the highest number of patients during the study period (2021-2034)?
• What would be the total number of patients of Presbyopia across the 7MM during the study period (2021-2034)?
• Among the EU5 countries, which country will have the highest number of patients during the study period (2021-2034)?
• At what CAGR the patient population is expected to grow in the 7MM during the study period (2021-2034)?
• What are the various recent and upcoming events which are expected to improve the diagnosis of Presbyopia?

Reasons to buy

The Presbyopia Epidemiology report will allow the user to -

• Develop business strategies by understanding the trends shaping and driving the global Presbyopia market
• Quantify patient populations in the global Presbyopia market to improve product design, pricing, and launch plans
• Organize sales and marketing efforts by identifying the gender that presents the best opportunities for Presbyopia therapeutics in each of the markets covered
• Understand the magnitude of Presbyopia population by its severity
• The Presbyopia epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists
• The Presbyopia Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over an 10-year forecast period using reputable sources

Key Assessments

• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population